Please use this identifier to cite or link to this item:
Title: Internet-based cognitive behavioural therapy (iCBT) for perinatal anxiety and depression versus treatment as usual: study protocol for two randomised controlled trials.
Austin Authors: Loughnan, Siobhan A;Newby, Jill M;Haskelberg, Hila;Mahoney, Alison;Kladnitski, Natalie;Smith, Jessica;Black, Emma;Holt, Christopher;Milgrom, Jeannette ;Austin, Marie-Paule;Andrews, Gavin
Affiliation: Perinatal & Women's Mental Health Unit, c/o St John of God Hospital, 13 Grantham Street, Burwood, NSW, 2134, Australia
Clinical Research Unit for Anxiety and Depression (CRUfAD), UNSW School of Psychiatry at St Vincent's Hospital, St Vincent's Hospital, Sydney, NSW, Australia
School of Psychology, Faculty of Science, UNSW Sydney, 1302 Mathews Building, Kensington, NSW, 2052, Australia
Melbourne School of Psychological Science, Austin Health, Heidelberg Repatriation Hospital, Heidelberg West, Victoria, Australia
Parent-Infant Research Institute, Austin Health, Heidelberg, Victoria, Australia
Issue Date: 22-Jan-2018
Date: 2018
Publication information: Trials 2018; 19(1): 56
Abstract: We aimed to evaluate the acceptability and efficacy of two brief, Internet-delivered cognitive behavioural therapy interventions-MUMentum Pregnancy (study 1) and MUMentum Postnatal (study 2)-in reducing maternal symptoms of anxiety, depression and overall psychological distress compared to usual care in the perinatal period. Women who are pregnant (study 1) or < 12 months postpartum (study 2) with current clinically elevated symptoms of anxiety and/or depression according to validated self-report measures, will be recruited via the research arm of a not-for-profit clinical and research unit in Australia and randomised to the intervention group or treatment as usual control group. The minimum sample size for each study (alpha 0.05; power 0.80 for a g of 0.80) was identified as 50 with at least 10% more to be recruited to account for expected attrition. The co-primary outcome measures are the Patient Health Questionnaire 9-item scale and Generalised Anxiety Disorder 7-item scale to measure depression and anxiety symptom severity, respectively, and will be administered at the following primary time-points: baseline; post treatment; and at one-month follow-up. Psychological distress will be measured according to the Kessler-10 psychological distress scale at each primary time-point and will also be completed before each lesson for those in the intervention group. The total trial period nine weeks for study 1 and 11 weeks for study 2. Program efficacy will be determined using intent-to-treat mixed models. Maintenance of gains will be assessed at one-month follow-up. The current randomised controlled trial seeks to extend the literature by evaluating the efficacy of a self-help intervention for women in the perinatal period. If efficacious, the MUMentum programs have the potential to be easily disseminated via to large numbers of women across Australia as an intervention for women screening positive for anxiety, depressive or distress symptoms during pregnancy or postpartum. Australian New Zealand Clinical Trials Registry, ACTRN12616000560493 ; ACTRN12616000559415 . Registered on 2nd May 2016.
DOI: 10.1186/s13063-017-2422-5
ORCID: 0000-0002-4082-4595
Journal: Trials
PubMed URL: 29357918
PubMed URL:
Type: Journal Article
Subjects: Antenatal
Cognitive behavioural therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 4, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.